Simulations Plus, Inc. (SLP)
NASDAQ: SLP · IEX Real-Time Price · USD
46.70
-0.02 (-0.04%)
May 3, 2024, 4:00 PM EDT - Market closed

Simulations Plus Revenue

Simulations Plus had revenue of $64.67M in the twelve months ending February 29, 2024, with 18.86% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $18.31M with 16.22% year-over-year growth. In the fiscal year ending August 31, 2023, Simulations Plus had annual revenue of $59.58M with 10.52% growth.

Revenue (ttm)
$64.67M
Revenue Growth
+18.86%
P/S Ratio
14.43
Revenue / Employee
$336,813
Employees
192
Market Cap
933.29M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 202359.58M5.67M10.52%
Aug 31, 202253.91M7.44M16.01%
Aug 31, 202146.47M4.88M11.73%
Aug 31, 202041.59M7.62M22.43%
Aug 31, 201933.97M4.30M14.51%
Aug 31, 201829.67M5.53M22.90%
Aug 31, 201724.14M4.17M20.86%
Aug 31, 201619.97M1.66M9.05%
Aug 31, 201518.31M6.85M59.80%
Aug 31, 201411.46M1.39M13.80%
Aug 30, 201310.07M622.16K6.58%
Aug 31, 20129.45M709.87K8.12%
Aug 31, 20118.74M-1.97M-18.42%
Aug 31, 201010.71M1.57M17.16%
Aug 31, 20099.14M175.30K1.95%
Aug 31, 20088.97M110.16K1.24%
Aug 31, 20078.86M3.00M51.28%
Aug 31, 20065.86M1.10M23.20%
Aug 31, 20054.75M-454.03K-8.72%
Aug 31, 20045.21M-278.05K-5.07%
Aug 31, 20035.48M1.04M23.42%
Aug 31, 20024.44M529.26K13.52%
Aug 31, 20013.91M285.03K7.85%
Aug 31, 20003.63M162.75K4.69%
Aug 31, 19993.47M821.65K31.06%
Aug 31, 19982.65M152.06K6.10%
Aug 31, 19972.49M-107.69K-4.14%
Aug 31, 19962.60M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 334.51M
Standard BioTools 106.34M
MacroGenics 58.75M
EyePoint Pharmaceuticals 46.02M
Relay Therapeutics 25.55M
Abivax 5.13M
Revenue Rankings